Hubei Haosun Pharmaceutical Co., Ltd., Ezhou, China – FDA Inspections

Inspection records and compliance data for Hubei Haosun Pharmaceutical Co., Ltd. in Ezhou. 5 FDA inspections on record, last inspected August 01, 2025.

Company Profile

This profile covers Hubei Haosun Pharmaceutical Co., Ltd. based in Ezhou, China.

FDA Inspection History

FDA inspections: 5
OAI: 0
VAI: 3
NAI: 1
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected July 16, 2011. Last inspected August 1, 2025.

FDA inspections (5)

Date	Result	FDA center(s)	Insp. #
August 1, 2025	Not classified	Human Drugs	1280335
March 9, 2018	NAI	Human Drugs · Drug Quality Assurance	1047621
September 2, 2016	VAI	Human Drugs · Drug Quality Assurance	988662
November 15, 2013	VAI	Human Drugs · Drug Quality Assurance	867397
July 16, 2011	VAI	Human Drugs · Drug Quality Assurance	738545

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (2)

EMA · 1 inspection · last January 20, 2016
China NMPA · 8 inspections · last October 31, 2019

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Dishman Carbogen Amcis Limited

Changzhou Yinsheng Pharmaceutical Co. Ltd.

Jiangxi Synergy Pharmaceutical, Co., Ltd.

Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

HEC Pharm Co., Ltd.

Wuhan Biocause Pharmaceutical Development Co., Ltd.

Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)

Anqiu Lu'an Pharmaceutical Co., Ltd.

Alchem International Ltd.

Arevipharma GmbH